Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global E Online Ltd (GLBE) vs Moderna, Inc. (MRNA) Price & Performance

Global E Online LtdTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Global E Online Ltd vs Moderna, Inc. — how do they compare? Global E Online Ltd trades at $40.8 (market cap $6.90B), while Moderna, Inc. trades at $60.84 (market cap $23.88B). The key difference: Moderna, Inc. is far larger — about 3.5× Global E Online Ltd's market cap, and Global E Online Ltd is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

GLBEMRNA
Market Cap
$6.90B$23.88B
Sector
TechnologyHealth
52-Week High
$42.32$81.80
52-Week Low
$27.54$22.36
Enterprise Value
$6.37B$20.03B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global E Online Ltd

GLBE trades at $42.32, up 3.17% in the past 24 hours, near its 52-week high. The stock shows bullish technical signals with strong moving average support, though RSI indicates overbought conditions. Recent earnings have been mixed, with a beat in Q4 2025 but a miss in Q1 2026. The company reported 2025 revenue of $962.20 million and net income of $68.27 million, with profitability improving into 2026. Key developments include the acquisition of Passport to enhance logistics capabilities and a $500 million share repurchase program authorized by the board.

GLBE presents a growth opportunity with robust analyst support—100% buy ratings and a consensus price target of $44.75, suggesting upside potential. However, risks include high valuation multiples like a P/E of 61.33, competitive pressures in e-commerce enablement, and insider selling by the CEO. Investors should weigh the strong growth trajectory against premium valuation and market volatility.

Moderna, Inc.

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global E Online Ltd

Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.

Read more on GLBE

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA